187 related articles for article (PubMed ID: 85869)
1. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis.
Papapoulos SE; Clemens TL; Fraher LJ; Lewin IG; Sandler LM; O'Riordan JL
Lancet; 1979 Mar; 1(8117):627-30. PubMed ID: 85869
[TBL] [Abstract][Full Text] [Related]
2. Increased 1,25-dihydroxycholecalciferol as a cause of abnormal calcium metabolism in sarcoidosis.
Koide Y; Kugai N; Kimura S; Fujita T; Yamashita N; Hiramoto ; Sukegawa J; Ogata E; Yamashita K
J Clin Endocrinol Metab; 1981 Mar; 52(3):494-8. PubMed ID: 6257749
[No Abstract] [Full Text] [Related]
3. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid-responsive hypercalcemia with elevated serum 1-alpha, 25 dihydroxyvitamin D.
Frame B; Parfitt AM
Ann Intern Med; 1980 Sep; 93(3):449-51. PubMed ID: 7436165
[TBL] [Abstract][Full Text] [Related]
5. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D.
Barbour GL; Coburn JW; Slatopolsky E; Norman AW; Horst RL
N Engl J Med; 1981 Aug; 305(8):440-3. PubMed ID: 6894783
[No Abstract] [Full Text] [Related]
6. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.
Stern PH; De Olazabal J; Bell NH
J Clin Invest; 1980 Oct; 66(4):852-5. PubMed ID: 7419722
[TBL] [Abstract][Full Text] [Related]
7. Determination of circulating 25,26-dihydroxycholecalciferol in man by radioimmunoassay.
Fraher LJ; Clemens TL; Papapoulos SE; Redel J; O'Riordan JL
Clin Sci (Lond); 1980 Oct; 59(4):257-63. PubMed ID: 7428293
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum 1,25-dihydroxyvitamin D concentrations in the hypercalcemia of sarcoidosis: correction by glucocorticoid therapy.
Chesney RW; Hamstra AJ; DeLuca HF; Horowitz S; Gilbert EF; Hong R; Borcherding W
J Pediatr; 1981 Jun; 98(6):919-22. PubMed ID: 7229793
[No Abstract] [Full Text] [Related]
9. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
[TBL] [Abstract][Full Text] [Related]
10. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3.
Sandler LM; Winearls CG; Fraher LJ; Clemens TL; Smith R; O'Riordan JL
Q J Med; 1984; 53(210):165-80. PubMed ID: 6087399
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D metabolites in idiopathic infantile hypercalcaemia.
Martin ND; Snodgrass GJ; Cohen RD; Porteous CE; Coldwell RD; Trafford DJ; Makin HL
Arch Dis Child; 1985 Dec; 60(12):1140-3. PubMed ID: 3879160
[TBL] [Abstract][Full Text] [Related]
12. The absence of 24,25-dihydroxycholecalciferol in anephric patients.
Taylor CM; Mawer EB; Wallace JE; St John J; Cochran M; Russell RG; Kanis JA
Clin Sci Mol Med Suppl; 1978 Dec; 55(6):541-7. PubMed ID: 216522
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment.
Gibbs CJ; Peacock M
Postgrad Med J; 1986 Oct; 62(732):937-8. PubMed ID: 3774726
[TBL] [Abstract][Full Text] [Related]
14. Serum 1,25-dihydroxycholecalciferol in anephric, haemodialyzed and kidney-transplanted patients. Effect of vitamin D3 supplement.
Lund B; Clausen E; Friedberg M; Lund B; Moszkowicz M; Nielsen SP; Sørensen OH
Nephron; 1980; 25(1):30-3. PubMed ID: 6243405
[TBL] [Abstract][Full Text] [Related]
15. 1,25-dihydroxycholecalciferol in pathogenesis of hypercalcaemic sarcoidosis.
MacGregor GA
Lancet; 1979 May; 1(8124):1041. PubMed ID: 86767
[No Abstract] [Full Text] [Related]
16. Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects.
Juttmann JR; Visser TJ; Buurman C; de Kam E; Birkenhäger JC
Br Med J (Clin Res Ed); 1981 Apr; 282(6273):1349-52. PubMed ID: 6786491
[TBL] [Abstract][Full Text] [Related]
17. Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy.
Zerwekh JE; Pak CY; Kaplan RA; McGuire JL; Upchurch K; Breslau N; Johnson R
J Clin Endocrinol Metab; 1980 Aug; 51(2):381-6. PubMed ID: 6893205
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcemia with elevated dihydroxycholecalciferol levels and hypercalciuria. A parathyroid concentration-independent mechanism.
Silver J; Popovtzer MM
Arch Intern Med; 1984 Jan; 144(1):162-3. PubMed ID: 6691752
[TBL] [Abstract][Full Text] [Related]
19. The tubular maximum for calcium reabsorption in patients with chronic active thoracic sarcoidosis.
Broulik PD; Votava V; Pacovsky V
Eur Respir J; 1990 Apr; 3(4):447-9. PubMed ID: 2365038
[TBL] [Abstract][Full Text] [Related]
20. Circulating vitamin D metabolites and hypercalcaemia of malignancy.
Ralston SH; Cowan RA; Robertson AG; Gardner MD; Boyle IT
Acta Endocrinol (Copenh); 1984 Aug; 106(4):556-63. PubMed ID: 6548074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
